Yuck, we got rid of our NEW foldout couches because of worries about PBDE for our son. (at the time, my husband thought I was a bit loopy). I didn’t know it has such a huge impact on fertility. Ugh! My tip is to buy furniture from IKEA because they adhere to European standards–i.e., they already know to ban those @)(*#&$ chemicals there!:
If your home is your sanctuary, you might want to reconsider what you decorate it with, especially if you plan to get pregnant. A recent study out of the School of Public Health at the University of California in Berkeley has found that chemicals commonly used to fire-proof furniture, textiles, plastics and electronics manage to get into the bloodstream and apparently, exert a powerful influence on fertility.
The study involved 223 women who were trying to get pregnant. Those subjects who had high levels of certain fire-retardant chemicals in their blood took about twice as long to get pregnant as the women who had low levels. The chemicals, known as polybrominated diphenyl ethers, or PBDEs, became common in the 1970s. According to study author Dr. Km Harley, “For every tenfold increase in PBDEs in the blood, we saw a 30% to 50% decrease in the odds of becoming pregnant in any given month,” said study author Dr. Kim Harley.
read more here.
Posted on March 13, 2010 | Filed under Fertility News | Permalink
To help Conceive continue to provide women and couples with the best information and support they need for trying to conceive, we are asking for your input. Please give us your feedback and opinions by taking an online questionnaire. And as a thank you, you are automatically entered into a drawing for a chance to win a “Trying-to-Conceive Gift Pack,” which features products from First Response, OvaCue, Fairhaven Health, and Conceive Magazine valued at over 400.
For more details about the survey and the exclusive gift pack, click here.
Posted on March 13, 2010 | Filed under Fertility News | Permalink
But thought you’d enjoy this update. Legendary New York restaurant critic, Gael Greene, tastes and reports on Breast Milk Cheese…Never Thought I’d Get So Much Mileage Out of Cheese… originally appeared on About.com Breastfeeding on Friday, March 12th, 2010 at 16:15:40.Permalink Comment Email this
Posted on March 13, 2010 | Filed under Fertility News | Permalink
Natural Family Planning seminar March 18Voorhees SunFertility awareness with Natural Family Planning is a gathering, recording and interpreting of facts about what is happening during a woman’s fertility …
Posted on March 13, 2010 | Filed under Fertility News | Permalink
Alaska health officials have reported that the state’s gonorrhea rates increased by 69 in 2009 after remaining steady for years, the Anchorage Daily News reports. Susan Jones of the Alaska Department of Health and Social Services said the increase is the biggest one-year jump since the 1970s…
Posted on March 13, 2010 | Filed under Fertility News | Permalink
Mercy San Juan has four sets of triplets and a pair of twins, tooSacramento BeeAngela Wheeler, 41, who does marketing for a bank and lives in Granite Bay, had been trying to get pregnant for nine months when she underwent fertility …and more
Posted on March 13, 2010 | Filed under Fertility News | Permalink
Bill would ban embryo sales, human-animal ‘hybrids’Arizona RepublicOn its face, they say, the bill could restrict fertility procedures and prevent research. But they also believe it’s a bigger-picture step by the state’s …
Posted on March 13, 2010 | Filed under Fertility News | Permalink
Are you familiar with our PCOS message boards? Now up and running, it’s a great place to meet other women with PCOS, get support from somebody who understands what you’re going through, and get your burning questions answered. So come on in and introduce yourself!Message Boards originally appeared on About.com PCOS on Friday, March 12th, 2010 at 21:27:59.Permalink Comment Email this
Posted on March 13, 2010 | Filed under Fertility News | Permalink
Home-fertility test for men set to arrive in storesVancouver SunA new device that looks a lot like home ovulation and home pregnancy tests but checks sperm count will soon be available in Europe, and is undergoing Food …
Posted on March 13, 2010 | Filed under Fertility News | Permalink
Current Affairs , Katie Powalski – posted by katie powalski on March, 12 2010 6:00 AM The best door prize I ever won was a bottle of coconut-scented body wash.
Posted on March 13, 2010 | Filed under Fertility News | Permalink
Transer was yesterday, it was as good as it could get. We transferred three embryos that ranged from a 7 cell grade A- to a 5 cell grade B. I am very optimistic and cannot wait to start posting some positive pregnancy tests. 
Posted on March 12, 2010 | Filed under Gestational Surrogates | Permalink
Paz Vega and husband Orson Salazar have revealed to Hola! magazine that they are expecting baby no. 3 in September! Though the couple had always planned on having more children, they admit that the news was unexpected.
“It’s a surprise,” says the 34-year-old Spanglish star. “This baby came a bit soon, but we’re thrilled and happy.”
Just thirteen weeks along, Paz says she wanted to wait until the end of her first trimester to share the exciting news: “Ava’s birth was very recent,” she explains. “And I have had two c-sections.”
Paz and Orson, who are already parents to son Orson, 2 ½, and Ava, 7 ½-months, are already trying to think up baby names: “Orson prefers a boy,” shares the soon-to-be mom-of-three. “Personally I have always liked boys, but if it’s a girl, marvelous, because I was raised among women.”
Congratulations to the Vega-Salazars!
Source
Posted on March 12, 2010 | Filed under Pregnancy | Permalink
For most people, the 2009 movie “Away We Go,” has all but faded from memory, a wry little comedy that didn’t gain much traction at the box office and was all but ignored during the past awards season.
But for some people one scene in that movie continues to echo at playgrounds, coffee shops and on city sidewalks. The characters Burt and Verona, played by John Krasinski and Maya Rudolph, arrive at the home of a friend and mother of young children, played by Maggie Gyllenhaal, and proudly present her with something she does not own: a stroller.
The result is not the warm “Thank you” they expect.
“I love my babies,” she exhorts before banishing the stroller from her house and flying into a rage. “Why would I want to push them away from me?”
And that’s exactly the question some parents are asking themselves these days. For them, the last decade’s coveted Bugaboo or Maclaren stroller has been largely supplanted by baby carriers — chic wraps, minimalist pouches and soft structured packs.
Hardly new, wraps and other types of baby carriers are traditional in many parts of the world, and Western versions have been used in North America and Europe for decades. But lately, “wearing” one’s baby has taken on a certain cachet, with celebrities like Brad Pitt and Keri Russell pictured in star-gazing magazines and blogs with their babies strapped to their bodies.
In recent years, the number of carriers has expanded from a handful of styles to scores. “In 2004, there were barely any carriers,” said Bianca Fehn, an owner of Metro Minis. “You had to find these work-at-home moms who made them and go on a waiting list for weeks or even months to get a carrier.” Before opening the store, she started an Internet community called Slings in the City that held regular baby carrier demonstrations around town.
But as carriers have grown more popular, their safety has been questioned, with particular alarm about bag-style slings, which have contributed to the suffocation deaths of several infants. On Tuesday, Inez M. Tenenbaum, the head of the Consumer Product Safety Commission, announced a forthcoming warning about slings, saying that “we know now the hazard scenarios for very small babies” carried in them. Many specialty stores, like Metro Minis, do not sell bag-style slings whose safety has been challenged, and instructs buyers to position babies in any sling upright and tight against the caregiver.
While most people using baby carriers extol the convenience of having their hands free to steer a toddler, dial a cellphone or maneuver through a grocery store, some see it as an integral part of their parenting philosophy, which holds that babies should be worn on the body to foster a strong attachment to their parents.
“Close physical contact is important for babies,” said Byron Egeland, a psychologist at the Institute of Child Development at the University of Minnesota, who has studied and written extensively about infant attachment. “But I would quickly add that a parent using a stroller is not going to make or break whether their child is securely or anxiously attached.”
Claire Moore, 33, nuzzled her 7-week-old daughter, Zoë, while explaining that her carrier had been picked by her husband, Adrian. Walking their dog most mornings in nearby Prospect Park, he had spent months during her pregnancy trying to figure out the most practical, comfortable carrier for them both by surveying the park’s many fathers with babies tethered to their chests. Eventually, Ms. Moore said, he settled on the ERGObaby; they bought one in cranberry.
“He’d been keeping an eye out and knew that was the one,” she said. “All the dads are wearing it.”
Source
Posted on March 12, 2010 | Filed under Pregnancy | Permalink
From the draft Panel Statement:
We are concerned about the barriers that women face in accessing clinicians and facilities that are able and willing to offer TOL [trial of labor]. Given the level of evidence for the requirement for “immediately available” surgical and anesthesia personnel in current guidelines, we recommend that the American College of Obstetricians and Gynecologists and the American Society of Anesthesiologists reassess this requirement relative to other obstetrical complications of comparable risk, risk stratification, and in light of limited physician and nursing resources. Healthcare organizations, physicians, and other clinicians should consider making public their TOL policy and VBAC rates, as well as their plans for responding to obstetric emergencies. We recommend that hospitals, maternity care providers, healthcare and professional liability insurers, consumers, and policymakers collaborate on the development of integrated services that could mitigate or even eliminate current barriers to TOL.
I know, the language itself doesn’t sound that exciting, but there is a lot of hope that it will have an effect in encouraging hospitals and providers with official VBAC bans and unofficial anti-VBAC stances to reconsider.
If you’re like me and had other work and life things in the way of catching the whole conference, video from days 1 and 2 and other materials are available from http://consensus.nih.gov/2010/vbac.htm. You can also poke through eleventy-billion tweets on the topic by searching for the hashtag #nihvbac. I’ll try to include some good blog posts on the topic in next Sunday’s round-up, as well.
I’m reserving judgment on the “women don’t have a settled right to refuse surgery” business until I actually get a chance to hear what was said in the day 3 video (which is not yet available) and telebriefing for myself, but Courtroom Mama has written about it for The Unnecesaran. Suffice it to say that I believe a woman has an absolute right to refuse any surgery, any time, for any reason – pregnant or not.
Filed under: Access, Rights, & Choice, Birth, Ethics, Events & Observances, Government 
Posted on March 12, 2010 | Filed under Womens Health News | Permalink
Objective: To investigate the effects of local inhibition of vascular endothelial growth factor A (VEGFA) on proliferation and apoptosis of follicular cells in rat ovaries. To analyze the role of the PI3K/AKT signaling pathway on VEGFA effects.Design: Experimental study.Setting: Research laboratory.Animal(s): Female Sprague Dawley rats, 21 days old, treated with equine chorionic gonadotropin (eCG).Main Outcome Measure(s): Follicular cell proliferation, apoptosis, and activation of the PI3K/AKT signaling pathway after intrabursal injection of a VEGFA inhibitor.Result(s): Inhibition of VEGFA leads to a decrease in the expression of the proliferation marker proliferating cell nuclear antigen (PCNA) in theca and granulosa cells (GC) and an increase in the activation of caspase 3 in antral follicles. Furthermore, we observed a decrease in the phosphorylation of RAC-alpha serine/threonine-protein kinase (AKT) and its target Bcl2 antagonist of cell death (BAD). No differences were found in the levels of kinase insert domain receptor (KDR) protein or in endothelial cell density.Conclusion(s): The VEGFA prevents apoptosis and stimulates proliferation of follicular cells, regulating follicular growth and development. The PI3K/AKT signaling pathway is one of the pathways involved in this mechanism. Therefore, VEGFA has a role as an antiapoptotic and proliferative factor in follicular cells from the rat ovary.
Posted on March 12, 2010 | Filed under Fertility News | Permalink
Objective: To analyze the expression and distribution of cannabinoid receptors in human sperm cells and evaluate the effects of activation of receptors by specific agonists and antagonists, with a special emphasis on the CB2 receptor.Design: We performed expression assays for CB1 and CB2 by reverse transcriptase PCR, Western blot, and immunofluorescence techniques in spermatozoa and performed motility analysis after incubation of semen samples with cannabinoid agonists and CB2 antagonist SR144528.Setting: Academic research laboratory.Patient(s): Semen from 50 normozoospermic, healthy human donors.Intervention(s): Spermatozoa isolated from semen by two consecutive swim-ups were used for all techniques.Main Outcome Measure(s): Reverse transcriptase PCR amplification gels, immunoblots, indirect immunofluorescence antibody assays, and percentage of motile sperm.Result(s): We have verified the presence of CB1 and CB2 receptors in human spermatozoa. The distribution of both of these receptors was distinct. Incubation with selective cannabinoid receptor agonists induced a significant reduction in the proportion of rapidly progressive motile spermatozoa, and whereas the CB1 agonist increased the proportion of immobile sperm cells, the CB2 receptor agonist increased the slow/sluggish progressive sperm cell population. The effect of the CB2 agonist was antagonized by the CB2-specific antagonist.Conclusion(s): The functional CB2 cannabinoid receptor is present in human spermatozoa and regulates the sperm motility in a more distinct manner than CB1.
Posted on March 12, 2010 | Filed under Fertility News | Permalink
Objective: To test the preventive role of exogenous T on spermatogenesis after cisplatin chemotherapy.Design: Placebo-controlled study.Setting: The animal laboratory of a medical university.Animal(s): Eighty-eight male BALB/c mice were divided into three groups; each group was subdivided into four groups.Intervention(s): Subgroups a received two or three cycles of cisplatin (2.5 mg/kg for 5 days + 16 days of recovery), subgroups b received the same chemotherapy regimen with adjuvant high-dose T enanthate (5 mg/100 g body weight) starting 1 week before chemotherapy and repeated every 21 days during chemotherapy, subgroups c received only high-dose T enanthate at the same dosage and intervals; subgroups d received a placebo.Main Outcome Measure(s): Testis spermatogenesis function was evaluated after 35 days (short term, group I) or 105 days (long term, groups II and III) of recovery, after the final dose of cisplatin, by histopathology and sperm count.Result(s): Testis tissue destruction and a significant dose-dependent decrease in spermatogenesis were identified in subgroups a. Both recovered partially during long-term recovery. Exogenous high-dose T caused damage to spermatogenesis, which was reversible (subgroups c). Adjuvant treatment with T had no additive long-term effect in animals treated with low-dose cisplatin (two cycles). However, a significant long-term preventive effect of T was seen in animals receiving high-dose cisplatin (three cycles).Conclusion(s): Hormonal intervention with exogenous T during chemotherapy had promising effects on spermatogenesis in mice receiving high-dose chemotherapy (regimens frequently used clinically). It had no additive long-term effects in animals receiving low-dose regimens.
Posted on March 12, 2010 | Filed under Fertility News | Permalink
Objective: To investigate a role for brain-derived neurotrophic factor (BDNF) in human oocyte maturation.Design: Prospective study.Setting: Research institute.Patients: Women undergoing laparoscopic sterilization.Intervention(s): Small antral follicle cumulus–oocyte complexes (COCs) were matured in vitro (IVM) to metaphase II (MII) in media with hormones (H; FSH, LH, E2), serum replacement (SR), BDNF, or blocking antibodies to BDNF (BDNF/AB and TrkB/Fc), and activated.Main Outcome Measure(s): The COCs were analyzed for expression of neurotrophin ligands/receptors and cumulus genes (HAS2, TNFAlP6, PTGS2, GREM1) by reverse transcription–polymerase chain reaction (RT-PCR), cumulus expansion, maturation to MII, and parthenogenetic embryo development.Result(s): The BDNF and truncated TrkB receptor were expressed in cumulus and mature oocytes. There was no difference in MII yields after IVM in control (H + SR) versus H + BDNF, H + SR + BDNF, or BDNF + SR media. However, both BDNF/AB and TrkB/Fc improved MII yields. After activation, normal cleavage was highest in H + SR (38%), whereas blocking antibodies yielded the highest abnormal cleavage (BDNF/AB 68%; TrkB/Fc 57%). Failure to cleave was highest in H + BDNF + SR (92%). Only H + SR yielded morulae/blastocysts (6%). Expression of GREM1 in cumulus increased after IVM in H + BDNF versus H + SR or in vivo maturation.Conclusion(s): The BDNF signaling within COCs influences oocyte maturation and early embryogenesis.
Posted on March 12, 2010 | Filed under Fertility News | Permalink
Objective: To study the effect of c-FLIP overexpression in testicular germ cells.Design: A novel transgenic mouse model overexpressing the apoptotic modulator c-FLIP in the testis was generated.Setting: Animal facility and university research laboratory.Animal(s): Transgenic mice overexpressing the long isoform of c-FLIP (c-FLIPL) under the transcriptional control of a 400 bp long regulatory region of the Stra8 promoter.Intervention(s): Spermatozoa motility and testis histological, immunohistochemical, and Western blot analyses were carried out in transgenic and control derived specimens.Main Outcome Measure(s): Testis morphology, sperm motility, and germ cell apoptosis were assayed.Results: Stra8 promoter was found to activate the ectopic overexpression of c-FLIPL in round and elongated spermatids. As a consequence of such overexpression, a dramatic loss of germ cells was observed, resulting in testicular atrophy associated with reduced sperm motility.Conclusion(s): The data show that c-FLIPL forced expression in haploid male germ cells has detrimental effects on spermatogenesis and sperm quality and reveal a possible mechanism underlying the onset of testicular atrophy.
Posted on March 12, 2010 | Filed under Fertility News | Permalink
Objective: To study using immunohistochemistry the localization of P2X receptor subtypes on the head of immature sperm in the human, mouse, hamster, and rat caput epididymidis.Design: Basic research.Setting: University-based hospital.Patient(s): Three human epididymides were obtained from patients undergoing orchidectomy for metastatic prostate cancer.Main Outcome Measure(s): P2X1, P2X2, P2X3, and P2X4 receptor immunolocalization on sperm.Result(s): In the present study, P2X1,2, and 3 receptor localization was immunohistochemically demonstrated on the head of immature sperm in the human, mouse, hamster, and rat caput epididymidis. P2X4 receptor immunostaining was also observed on the head of sperm in the caput epididymidis of mice, hamsters, and humans, but not rats. There was a subsequent loss of receptor staining on sperm in the cauda epididymidis, except in humans where staining of P2X4 receptors persisted. Comparision with peanut agglutinin (PNA) binding studies suggested the P2X receptors were located on the acrosome membrane. P2X5–7 receptors were examined but found to be absent.Conclusion(s): The change in localization of receptor subtypes is coincidental with the functionally essential morphologic and maturational changes seen in sperm as they travel through the epididymis, and is suggestive of a role for purinergic signaling in sperm maturation and possibly fertility.
Posted on March 12, 2010 | Filed under Fertility News | Permalink
Objective: To determine intrafollicular hormone levels and characterize the mRNA expression of the insulin-like growth factor (IGF) receptors, IGF binding proteins (IGFBP), and pregnancy-associated plasma protein-A (PAPP-A) in granulosa cells before and after an ovulatory hCG stimulus.Design: Experimental animal study.Setting: Academic medical center.Animal(s): Adult rhesus macaques.Intervention(s): Animals received exogenous FSH to promote the development of multiple preovulatory follicles. Follicles were aspirated before (0 hours) or 3, 6, 12, or 24 hours after an ovulatory hCG bolus.Main Outcome Measure(s): IGF1, IGF2, and insulin levels in follicular fluid were determined by radioimmunoassay. Messenger RNA (mRNA) levels in granulosa cells were determined by real-time reverse transcriptase–polymerase chain reaction. IGFBPs and PAPP-A in follicular fluid were determined by Western blot analysis and enzyme-linked immunosorbent assay.Result(s): IGF1, IGF2, and insulin in follicular fluid did not change during luteinization. IGF1R, IGFBP1, and IGFBP2 mRNAs were unchanged by hCG. IGF2R, IGFBP3, -5, and -6 and PAPP-A mRNA levels increased after hCG administration, while insulin receptor and IGFBP4 mRNA levels decreased after hCG administration. IGFBP3 and -6 and PAPP-A protein increased after hCG administration.Conclusion(s): Dynamic changes in the expression of the IGFBPs and PAPP-A suggest tight regulation of IGF action during ovulation and corpus luteum formation.
Posted on March 12, 2010 | Filed under Fertility News | Permalink
Objective: To investigate the specific changes in oocyte spindle subjected to severe challenges of low temperature, as well as to examine the effect of cryoprotectants in preserving oocyte spindle during cryopreservation.Design: In vitro experimental study.Setting: Academic research laboratory.Animal(s): B6D2F1 (C57BL/6 X DBA/2) mice.Intervention(s): Mouse oocytes were cryopreserved using a slow freezing method in a sodium-depleted medium with 1.5 mol/l 1,2-propanediol (PROH) and 0.3 M sucrose. To examine the spindle, oocytes were fixed before, during, and after cryopreservation, and oocytes were analyzed by immunocytochemistry and confocal microscopy.Result(s): The MII spindle was preserved during the slow freezing, because the cryoprotectant PROH was found to support the organization of MII spindle in resisting the subzero temperature. In contrast, the MII spindle was disassembled gradually during the thawing process with or without PROH. Most of the oocytes were able to recover the MII spindle after thawing, but a portion of thawed oocytes could not sustain the meiotic spindle because of parthenogenetic activation.Conclusion(s): 1,2-Propanediol can support the organization of MII spindle to defy the subphysiologic temperature; however, the PROH cannot sustain oocyte spindle structure after the subsequent thawing process.
Posted on March 12, 2010 | Filed under Fertility News | Permalink
Objective: To examine the pro-resolution actions of 15-epi-lipoxin A4 (LXA4) on endometriotic lesions, on the concentrations and activities of matrix metalloproteinases (MMP-2 and MMP-9) in murine endometriosis.Design: Prospective, vehicle-controlled experimental study.Setting: Animal research facility.Animal(s): BALB/c mice.Intervention(s): Endometriosis (EM) was induced in 30 mice. Fifteen of them were administered LXA4 for 24 days (LXA4 group), whereas the other 15 served as a control group (EM group). Another 15 sham-operated mice (sham-operated group) were treated with vehicles.Main Outcome Measure(s): The weight of the endometriotic lesions was measured. The concentrations, mRNA, and activities of MMP-2 and MMP-9 were determined by enzyme-linked immunosorbent assay, quantitative real-time polymerase chain reaction, and gelatin zymography, respectively.Result(s): Compared with EM group, the weight of the endometriotic lesions was decreased, the concentrations of MMP-2 and MMP-9 dropped, the mRNA levels of MMP-2 and MMP-9 in the peritoneal fluid cells and the endometriotic lesions were reduced, and the activities of MMP-2 and MMP-9 were inhibited in the LXA4 group.Conclusion(s): LXA4 may inhibit the progression of endometriosis possibly by lowering the concentrations and the activities of MMP-2 and MMP-9.
Posted on March 12, 2010 | Filed under Fertility News | Permalink
Objective: To examine the change in proinflammatory cytokines in the pathologic processes of endometriosis in mice.Design: A dynamic study on a murine model of endometriosis.Setting: Medical school.Animal(s): Female BALB/c mice.Intervention(s): Endometriosis was induced by injecting endometrial fragments of syngenic mice into the peritoneal cavity of model mice; in control group, phosphate-buffered saline instead of fragments was injected. The peritoneal fluid and the endometriotic lesions were harvested 1 to 21 days after the induction.Main Outcome Measure(s): The endometriotic lesions were weighed, the gene and protein levels of some proinflammatory cytokines, including interleukin 1?, tumor necrosis factor ?, vascular endothelial growth factor, and monocyte chemoattractant protein 1, were determined by real-time quantitative polymerase chain reaction and enzyme-linked immunosorbent assay, respectively.Result(s): The levels of these cytokines reached the first peak on the first day and no endometriotic lesions were found. The lesions began to appear on the second day, presenting red color during the initial 6 days, and then they turned dark-red, brown, or bluish. The adhesion took place on the 9th day, and all the lesions evolved into white or transparent cysts on the 15th day. Corresponding to these changes, the second and the third peaks were identified during the 3rd–6th day and the 12th-15th day, respectively.Conclusion(s): The change pattern of cytokines over time might bear some relationship with the development and progression of the endometriosis.
Posted on March 12, 2010 | Filed under Fertility News | Permalink
Objective: To investigate protective effects of Marrubium cordatum extract on ovary torsion–detorsion.Design: Controlled research study.Setting: Marrubium cordatum extract was obtained by methanol extraction.Animal(s): Six-month-old female New Zealand rabbits.Intervention(s): In the first phase, antioxidant activity of M. cordatum extract was evaluated. In the second phase, M. cordatum extract at doses of 0, 250, 500, and 1,000 mg/kg was studied for dose determination. In the third phase, the protective role of M. cordatum on ovarian torsion–detorsion injury was evaluated in sham control, torsion–detorsion, torsion–detorsion + M. cordatum (1,000 mg/kg).Main Outcome Measure(s): 1,1-Diphenyl-2-picrylhydrazyl, nitric oxide radical scavenging activity, reducing power capacity, and total phenolic compounds were assayed. Glutathione, malondialdehyde, catalase, and glutathione peroxidase were measured. Histopathological examination was also conducted.Result(s): Marrubium cordatum significantly inhibited 1,1-diphenyl-2-picrylhydrazyl, nitric oxide radicals, and showed a powerful reducing activity. Marrubium cordatum did not adversely affect biochemical and histopathological parameters at all doses. Malondialdehyde level and catalase activity in the torsion–detorsion group were significantly increased compared with those of the sham group, whereas the glutathione level and glutathione peroxidase activity were significantly decreased compared with those of the sham group. Marrubium cordatum treatment significantly lowered the malondialdehyde level and catalase activity but increased the glutathione level in torsion–detorsion injury. Histopathologically, severe congestion, hemorrhage, edema, and leukocyte infiltration were observed in the torsion–detorsion group. Marrubium cordatum treatment ameliorated these alterations.Conclusion(s): Marrubium cordatum attenuates ischemia–reperfusion-induced biochemical and histopathological alterations.
Posted on March 12, 2010 | Filed under Fertility News | Permalink
Next »
Copyright @ 2001 and Beyond Fertility Portal: Fertility and Infertility Research News
Web Design By Dynamic Creator | Web Hosting by Trade Web Hosting
